President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

“Cell and gene therapy manufacturing, supply chains and delivery are all very complex,” Anita Ralli, chair of the Collective and associate director of government affairs at Gilead ...

"The potential of BlueRock and AskBio's clinical candidates to treat Parkinsons disease could be immense," said Wolfram Carius, head of cell and gene therapy at Bayer. "For the first time ...

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Asiawu Imam says the therapy will make a huge difference A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England.

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts say.